Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists

Title:Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists

Volume: 22 Issue: 29

Author(s): Jan Honegr, Ondrej Soukup, Rafael Dolezal, David Malinak, Marek Penhaker, Roman Prymula and Kamil Kuca

Affiliation:

Keywords: Immunologic adjuvants, TLR, vaccines, SMIP, innate immunity, drug design, targeting, Toll-like receptor.

Abstract: Toll like receptors (TLRs) are a family of transmembrane proteins which play a key role in innate immunity. When TLRs come into contact with a potential threat, they initiate a signaling cascade leading to release of cytokines and chemokines, maturation of antigen presenting cells and immune activation. Molecules which can activate TLRs may be utilized for vaccine development and act as vaccine adjuvants. Adjuvants can facilitate production of more effective vaccines based on antigens produced by recombinant techniques or by DNA vaccines, which are often poorly immunogenic since they lack the endogenous innate immunostimulatory components of the pathogen. In this paper the structural properties of such prospective compounds are thoroughly discussed.

Cite this article as:

Honegr Jan, Soukup Ondrej, Dolezal Rafael, Malinak David, Penhaker Marek, Prymula Roman and Kuca Kamil, Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists, Current Medicinal Chemistry 2015; 22 (29) . https://dx.doi.org/10.2174/0929867322666150821094634